| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5443815 | CIS BIO INTL SA | Technetium-99m labeled peptides for imaging |
Aug, 2012
(11 years ago) | |
| US5508020 | CIS BIO INTL SA | Technetium-99M labeled peptides for imaging |
Apr, 2013
(11 years ago) | |
| US5645815 | CIS BIO INTL SA | Radiolabled compounds for thrombus imaging |
Jul, 2014
(9 years ago) | |
Acutect is owned by Cis Bio Intl Sa.
Acutect contains Technetium Tc-99M Apcitide.
Acutect has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Acutect are:
- US5443815
- US5508020
- US5645815
Acutect was authorised for market use on 14 September, 1998.
Acutect is available in injectable;injection dosage forms.
The generics of Acutect are possible to be released after 08 July, 2014.
Drugs and Companies using TECHNETIUM TC-99M APCITIDE ingredient
Market Authorisation Date: 14 September, 1998
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
ACUTECT family patents
